Standout Papers

Global incidence and prev... 2021 2026 2022 2024 2022 2022 2022 2021 2022 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. Global incidence and prevalence of nonalcoholic fatty liver disease
    2022 334 citations Margaret LP Teng, Cheng Han Ng et al. Clinical and Molecular Hepatology profile →
  2. Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis
    2022 281 citations Ainsley Ryan Yan Bin Lee, Shi Yin Wong et al. BMJ profile →
  3. Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 Individuals
    2022 177 citations Kai En Chan, Ansel Shao Pin Tang et al. The Journal of Clinical Endocrinology & Metabolism profile →
  4. An Observational Data Meta-analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD
    2021 162 citations Grace En Hui Lim, Ansel Shao Pin Tang et al. Clinical Gastroenterology and Hepatology profile →
  5. Mortality Outcomes by Fibrosis Stage in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis
    2022 101 citations Cheng Han Ng, Wen Hui Lim et al. Clinical Gastroenterology and Hepatology profile →
  6. Patterns in Cancer Incidence Among People Younger Than 50 Years in the US, 2010 to 2019
    2023 88 citations Benjamin Koh, Darren Jun Hao Tan et al. JAMA Network Open profile →

Immediate Impact

83 hit
Sub-graph 1 of 18

Citing Papers

Liver diseases: epidemiology, causes, trends and predictions
2025 Hit
Metabolic Dysfunction–Associated Steatotic Liver Disease
2025 Hit
27 intermediate papers

Works of Mark Muthiah being referenced

Placebo effect on progression and regression in NASH: Evidence from a meta‐analysis
2022
Burden of Disease due to Nonalcoholic Fatty Liver Disease
2020
and 23 more

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Mark Muthiah 2.4k 1.2k 1.0k 621 523 182 4.0k
George Cholankeril 2.9k 1.2× 1.8k 1.5× 864 0.8× 599 1.0× 368 0.7× 145 4.0k
Sanjaya K. Satapathy 2.5k 1.1× 1.7k 1.4× 676 0.7× 821 1.3× 377 0.7× 170 3.7k
Tracey G. Simon 3.5k 1.5× 2.0k 1.7× 1.2k 1.1× 680 1.1× 552 1.1× 109 4.9k
Norberto C. Chávez‐Tapia 2.8k 1.2× 1.7k 1.4× 908 0.9× 1.2k 1.9× 699 1.3× 193 4.7k
Nimer Assy 2.0k 0.8× 1.1k 0.9× 1.0k 1.0× 570 0.9× 336 0.6× 92 3.1k
Wah‐Kheong Chan 2.7k 1.1× 1.4k 1.2× 1.1k 1.0× 763 1.2× 341 0.7× 112 3.6k
Karn Wijarnpreecha 1.9k 0.8× 991 0.8× 564 0.5× 962 1.5× 257 0.5× 250 4.0k
Farhad Zamani 1.6k 0.7× 650 0.5× 835 0.8× 519 0.8× 762 1.5× 179 3.5k
Christian Datz 3.0k 1.3× 2.0k 1.7× 819 0.8× 592 1.0× 875 1.7× 176 6.3k
Marcin Krawczyk 1.8k 0.7× 894 0.7× 596 0.6× 1.0k 1.7× 472 0.9× 203 3.3k

All Works

Loading papers...

Rankless by CCL
2026